Red blood cells participate in the metabolic clearance of catecholamines in the rat

Life Sciences

Volumn 60, Issue 6, 1997, Pages 357-367

  Azoui, Rachida ^a   Schneider, Joëlle ^a   Dong, Wen Xin ^a   Dabiré, Hubert ^a   Safar, Michel ^a   Cuche, Jean Louis ^a,b  

^a INSERM   (France)

^b Lab Biol Des Catécholamines   (France)

Author keywords

1,2 dimethyl 3 hydroxy 4 pyridone (CP20); dopamine; epinephrine; glucuroconjugated catecholamines; norepinephrine

Indexed keywords

ADRENALIN; CATECHOL METHYLTRANSFERASE INHIBITOR; CATECHOLAMINE; DEFERIPRONE; DOPAMINE; NORADRENALIN;

AMINE TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE LEVEL; GLUCURONIDATION; HEART RATE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; METABOLIC CLEARANCE RATE; NONHUMAN; RAT;

ANIMALS; BLOOD PRESSURE; CATECHOLAMINES; DOPAMINE; EPINEPHRINE; ERYTHROCYTES; HEART RATE; INFUSIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; NOREPINEPHRINE; PYRIDONES; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 0031040481     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(96)00659-5     Document Type: Article

References (21)

1. R. AZOUI, D. VIGNON, M. SAFAR and J.L. CUCHE, J. Cardiovasc. Pharmacol. 23 525-531 (1994).
2. J. AXELROD and C.K. COHN, J. Pharmacol. Exp. Ther. 176 650-654 (1971).
3. S.YONEDA, N. ALEXANDER, N.D.VLACHAKIS and R.F. MARONDE, Am. J. Physiol. 247 R208-R211 (1984).
4. R.M. WEINSHILBOUM and R.J. ANDERSON, Phenolsulfotransferase in Mental Health Research, eds: Sandler M, Usdin E. MacMillan Publishers Ltd, 8-28London (1981).
5. N. ALEXANDER, M. VELASQUEZ and N.D. VLACHAKIS, Life. Sci. 29 477-482 (1981).
6. N. Alexander, S. Yoneda , N.D. Vlachakis and R.F. Maronde, Am. J. Physiol. 247 R203-R207 (1984).
7. M. BOUVIER, L. FARLEY and J. DE CHAMPLAIN, Am. J. Physiol. 253 H270-H275 (1987).
8. J.B. PORTER , E.R. HUEHNS and R.C. HIDER, Bailliere's. Clin. Haematol. 2 257-292 (1989).
9. G.J. KONTOGHIORGHES, Br. Med. J. 303 1279-1280 (1991).
10. R.T. BORCHARDT, J. Med. Chem. 16 581-583 (1973).
11. P.C. WALDMEIER, A.M. BUCHLE and A.F. STEULET, Biochem. Pharmacol. 45 2417-2423 (1993).
12. J.P. CLAUSTRE, P. SERUSCLAT and L. PEYRIN, J. Neur. Trans. 56 265 -278 (1983).
13. P.C. WANG, O. KUCHEL, N.T. BUU and J. GENEST, J. Neurochem. 40 1435-1440 (1983).
14. S. YONEDA, N. ALEXANDER and N.D. VLACHAKIS, Life. Sci. 33 935-942 (1983).
15. J.L. CUCHE, J. PRINSEAU, F. SELZ and G. RUGET, Hypertension. 7 81-89 (1985).
16. J.L. CUCHE, G. JONDEAU, G. RUGET, F. SELZ, J.C. PIGA and C. HARBOUN, Pharmacology. 32 90-100 (1986).
17. B.FRIEDGEN, T. HALBRÜGGE and K.H. GRAEFE, J Cardiovasc Pharmacol. 21 21-28 (1993).
18. R. BLUTH and H. BANASCHAK, Acta. Biol. Med. Gem. 35 709-713 (1976).
19. H. BANASCHAK and R. BLUTH, Int. J. Clin. Pharmacol. 16. 336-339 (1978).
20. R. AZOUI, J.L. CUCHE, J.F. RENAUD, M. SAFAR and G. DAGHER, Experimental Physiol. 81.-421-434 (1996)
21. D. RATGE, P.K. KOHSE, and H. STEEGMÜLLER WISSER, J. Pharmacol. Exp. Ther. 257 232-238 (1991).